Total Payments
$2,245
2024 Payments
$134.83
Companies
17
Transactions
124
Medicare Patients
14,772
Medicare Billing
$1.2M
Payment Breakdown by Category
Food & Beverage$2,238 (99.7%)
Education$6.97 (0.3%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,238 | 123 | 99.7% |
| Education | $6.97 | 1 | 0.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Abbott Laboratories | $538.70 | 25 | $0 (2022) |
| Janssen Pharmaceuticals, Inc | $449.21 | 24 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $252.68 | 14 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $196.78 | 14 | $0 (2024) |
| Merck Sharp & Dohme LLC | $188.67 | 10 | $0 (2023) |
| BIOTRONIK INC. | $159.83 | 9 | $0 (2024) |
| Amgen Inc. | $68.16 | 4 | $0 (2022) |
| Medtronic Vascular, Inc. | $60.08 | 4 | $0 (2020) |
| SANOFI-AVENTIS U.S. LLC | $55.78 | 3 | $0 (2023) |
| CVRx, Inc. | $55.57 | 4 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $134.83 | 7 | E.R. Squibb & Sons, L.L.C. ($47.00) |
| 2023 | $211.41 | 12 | Merck Sharp & Dohme LLC ($109.69) |
| 2022 | $333.33 | 21 | Janssen Pharmaceuticals, Inc ($124.47) |
| 2021 | $173.88 | 10 | Merck Sharp & Dohme Corporation ($60.17) |
| 2020 | $170.13 | 11 | BIOTRONIK INC. ($81.44) |
| 2019 | $276.03 | 14 | Abbott Laboratories ($141.03) |
| 2018 | $329.34 | 19 | Abbott Laboratories ($156.15) |
| 2017 | $615.97 | 30 | Abbott Laboratories ($229.60) |
All Payment Transactions
124 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/22/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $18.18 | General |
| Category: Cardiovascular | ||||||
| 10/17/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $26.26 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/03/2024 | BIOTRONIK INC. | AMVIA EDGE (Device) | Food and Beverage | In-kind items and services | $25.70 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 04/30/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $17.40 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 03/26/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $14.38 | General |
| Category: Cardiovascular | ||||||
| 03/06/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $18.47 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 02/13/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $14.44 | General |
| Category: Cardiovascular | ||||||
| 11/22/2023 | CVRx, Inc. | Barostim Neo System (Device) | Food and Beverage | Cash or cash equivalent | $3.93 | General |
| Category: Heart Failure and Hypertension | ||||||
| 09/20/2023 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $18.35 | General |
| Category: CARDIOVASCULAR | ||||||
| 08/23/2023 | CVRx, Inc. | Barostim Neo System (Device) | Food and Beverage | Cash or cash equivalent | $16.62 | General |
| Category: Heart Failure and Hypertension | ||||||
| 06/28/2023 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $15.13 | General |
| Category: CARDIOVASCULAR | ||||||
| 05/24/2023 | SANOFI-AVENTIS U.S. LLC | MULTAQ (Drug) | Food and Beverage | In-kind items and services | $17.79 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 05/10/2023 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $20.86 | General |
| Category: CARDIOVASCULAR | ||||||
| 04/26/2023 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $16.13 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 03/22/2023 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $20.83 | General |
| Category: CARDIOVASCULAR | ||||||
| 03/07/2023 | Kestra Medical Technology Services, Inc. | Assure WCD (Device) | Food and Beverage | Cash or cash equivalent | $33.42 | General |
| Category: Cardiology | ||||||
| 02/22/2023 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $21.15 | General |
| Category: CARDIOVASCULAR | ||||||
| 01/25/2023 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $13.83 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 01/11/2023 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $13.37 | General |
| Category: CARDIOVASCULAR | ||||||
| 12/27/2022 | BIOTRONIK INC. | Edora 8 DR-T (Device), Rivacor 7 DR-T | Food and Beverage | In-kind items and services | $15.11 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 12/06/2022 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $9.03 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 10/26/2022 | Merck Sharp & Dohme LLC | VERQUVO (Drug) | Food and Beverage | In-kind items and services | $18.81 | General |
| Category: CARDIOVASCULAR | ||||||
| 10/25/2022 | PFIZER INC. | VYNDAQEL (Drug) | Food and Beverage | In-kind items and services | $12.45 | General |
| Category: CARDIOVASCULAR | ||||||
| 10/19/2022 | CVRx, Inc. | Barostim Neo System (Device) | Food and Beverage | Cash or cash equivalent | $17.04 | General |
| Category: Heart Failure and Hypertension | ||||||
| 10/12/2022 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $17.12 | General |
| Category: Cardiovascular & Metabolism | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 24 | 3,406 | 4,474 | $878,100 | $213,694 |
| 2022 | 24 | 3,590 | 4,878 | $1.1M | $217,796 |
| 2021 | 34 | 4,054 | 6,186 | $1.6M | $386,290 |
| 2020 | 30 | 3,722 | 5,479 | $1.4M | $337,785 |
Total Patients
14,772
Total Services
21,017
Medicare Billing
$1.2M
Procedure Codes
124
All Medicare Procedures & Services
124 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 680 | 1,103 | $351,643 | $84,715 | 24.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 403 | 539 | $115,598 | $25,575 | 22.1% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 191 | 288 | $68,910 | $18,162 | 26.4% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 289 | 291 | $59,219 | $15,144 | 25.6% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 76 | 127 | $45,775 | $12,074 | 26.4% |
| 99221 | Initial hospital care with straightforward or low level of medical decision making, per day, if using time, at least 40 minutes | Facility | 2023 | 173 | 176 | $44,736 | $11,507 | 25.7% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 205 | 209 | $46,271 | $11,087 | 24.0% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Office | 2023 | 94 | 95 | $23,666 | $6,206 | 26.2% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 76 | 76 | $20,704 | $4,866 | 23.5% |
| 93280 | Programming of dual lead pacemaker system | Office | 2023 | 88 | 154 | $16,924 | $3,757 | 22.2% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Facility | 2023 | 53 | 53 | $12,084 | $3,181 | 26.3% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Office | 2023 | 358 | 415 | $10,331 | $2,363 | 22.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 22 | 22 | $9,365 | $2,017 | 21.5% |
| 93793 | Anticoagulant management of patient taking warfarin | Office | 2023 | 26 | 220 | $7,700 | $1,987 | 25.8% |
| 93016 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | Office | 2023 | 94 | 94 | $5,898 | $1,553 | 26.3% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 128 | 138 | $6,072 | $1,505 | 24.8% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 55 | 55 | $6,518 | $1,504 | 23.1% |
| 93018 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | Office | 2023 | 94 | 94 | $3,936 | $1,032 | 26.2% |
| 93284 | Programming of multiple lead implantable defibrillator system | Office | 2023 | 15 | 25 | $4,517 | $955.60 | 21.2% |
| 93016 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | Facility | 2023 | 53 | 53 | $3,339 | $875.56 | 26.2% |
| 93283 | Programming of dual lead implantable defibrillator system | Office | 2023 | 16 | 24 | $4,000 | $837.71 | 20.9% |
| 93308 | Ultrasound of heart, follow-up | Facility | 2023 | 40 | 41 | $3,065 | $773.11 | 25.2% |
| 93294 | Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | Office | 2023 | 26 | 29 | $2,608 | $665.00 | 25.5% |
| 93018 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | Facility | 2023 | 53 | 53 | $2,226 | $581.94 | 26.1% |
| 93244 | Heart rhythm review, and interpretation of continous external ekg over more than 48 hours up to 7 days | Office | 2023 | 18 | 18 | $1,276 | $333.18 | 26.1% |
About Dr. Deo Sankar, MD
Dr. Deo Sankar, MD is a Cardiovascular Disease healthcare provider based in Sebring, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/12/2006. The National Provider Identifier (NPI) number assigned to this provider is 1952380594.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Deo Sankar, MD has received a total of $2,245 in payments from pharmaceutical and medical device companies, with $134.83 received in 2024. These payments were reported across 124 transactions from 17 companies. The most common payment nature is "Food and Beverage" ($2,238).
As a Medicare-enrolled provider, Sankar has provided services to 14,772 Medicare beneficiaries, totaling 21,017 services with total Medicare billing of $1.2M. Data is available for 4 years (2020–2023), covering 124 distinct procedure/service records.
Ad
Practice Information
- Specialty Cardiovascular Disease
- Location Sebring, FL
- Active Since 01/12/2006
- Last Updated 06/24/2024
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1952380594
Products in Payments
- XARELTO (Drug) $449.21
- ELIQUIS (Drug) $197.10
- ENTRESTO (Drug) $194.67
- VERQUVO (Drug) $188.67
- CRT-Ds (Device) $120.93
- Connectivity and Remote care (Device) $100.60
- CRT-Ps (Device) $75.10
- Repatha (Biological) $68.16
- Unify Assura CRT Defibrillator (Device) $66.42
- LEQVIO (Drug) $58.01
- Barostim Neo System (Device) $55.57
- Assurity Pacemaker (Device) $46.96
- LifeVest (Device) $43.48
- Quadra Assura CRT Defibrillator (Device) $42.93
- Confirm Rx (Device) $42.15
- MULTAQ (Drug) $35.10
- Assure WCD (Device) $33.42
- VYNDAQEL (Drug) $28.93
- AMVIA EDGE (Device) $25.70
- Reveal LINQ (Device) $21.97
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Sebring
Mr. Daniel Parnassa, Md, MD
Cardiovascular Disease — Payments: $15,855
Cardiovascular Disease $15,855
Dr. Rakesh Sharma, M.d, M.D
Cardiovascular Disease — Payments: $10,129
Cardiovascular Disease $10,129
Ms. Joan Siracuse, Md, MD
Cardiovascular Disease — Payments: $7,744
Cardiovascular Disease $7,744
Ramon Torres, Md, MD
Cardiovascular Disease — Payments: $6,611
Cardiovascular Disease $6,611
Dr. George Leef, Md, MD
Cardiovascular Disease — Payments: $5,594
Cardiovascular Disease $5,594
Harini Lakshman, Md, MD
Cardiovascular Disease — Payments: $4,683
Cardiovascular Disease $4,683